Uncategorized – Boston Collaborative Drug Surveillance Program (BCDSP)

Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real-world data

By BCDSP March 31, 2024Uncategorized

Journal: Pharmacoepidemiology and Drug Safety Authors: Paul Muntner, Rohini K Hernandez, Shia T Kent, James E Browning, David T Gilbertson, Kathleen E Hurwitz, Susan S Jick, Edward C Lai, Timothy L Lash, Keri L Monda, Kenneth J Rothman, Brian D Bradbury, M…

Extent of apremilast exposure misclassification in CPRD Aurum: a validation study

By BCDSP August 24, 2023Uncategorized

Presented: ICPE 2023 in Halifax, Nova Scotia Authors: Rebecca Persson, Susan S Jick Download Full-Size Poster Abstract Background: United Kingdom general practice databases, including the Clinical Practice Research Datalink (CPRD),…

To Link or Not to Link: Insights from comparison of CPRD Aurum and CPRD GOLD with linked Hospital Episode Statistics (HES) APC, HES Outpatient, and Cancer Registry data

By BCDSP August 24, 2023Uncategorized

Presented: ICPE 2023 in Halifax, Nova Scotia Authors: Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza, Rebecca Persson, George Kafatos, David E Neasham, Susan S Jick Download Full-Size Poster Background: Clinical Practice Research…

Assessing the Risk of Developing Delirium on Admission to Inpatient Rehabilitation: A Clinical Prediction Model

By BCDSP August 10, 2023Uncategorized

Journal: Journal of the American Medical Directors Association Authors: Marco G Ceppi, Marlene S Rauch, Julia Spöndlin, Christoph R Meier, Peter S Sándor NLM Citation: Ceppi MG, Rauch MS, Spöndlin J, Meier CR, Sándor…

Characterization of the deterioration of diabetes control in patients with a subsequent diagnosis of pancreatic cancer: A descriptive study

By BCDSP March 14, 2023Uncategorized

Journal: Pancreatology Authors: Alexandra M Mueller, Christoph R Meier, Susan S Jick, Cornelia Schneider NLM Citation: Mueller AM, Meier CR, Jick SS, Schneider C. Characterization of the deterioration of diabetes control in patients…

β-Blockers and the Risk of Depression: A Matched Case-Control Study.

By BCDSP September 6, 2022Uncategorized

Journal: Drug Safety Authors: Delia Bornand, Daphne Reinau, Susan S Jick, Christoph R Meier NLM Citation: Bornand D, Reinau D, Jick SS, Meier CR. β-Blockers and the Risk of Depression: A Matched Case-Control…

Asthma drugs and the risk of congenital anomalies

By BCDSP June 14, 2022Uncategorized

Journal: Pharmacotherapy Authors: Catherine Vasilakis-Scaramozza, Ann Aschengrau, Howard J Cabral, Susan S Jick NLM Citation: Vasilakis-Scaramozza C, Aschengrau A, Cabral HJ, Jick SS. Asthma drugs and the risk of congenital…

Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments

By BCDSP May 3, 2022Uncategorized

Journal: Clinical Epidemiology Authors: Rebecca Persson, Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza, Eleanor Yelland, Tim Williams, Puja Myles, Susan S Jick NLM Citation: Persson R, Hagberg KW, Vasilakis-Scaramozza C, Yelland E, Williams T, Myles P, Jick SS.…

Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20-59 Years in the United Kingdom’s CPRD 1995-2015

By BCDSP January 20, 2022Uncategorized, Venous Thromboembolism (VTE)

Journal: Clinical Epidemiology Authors: Olulade A Ayodele, Howard J Cabral, David D McManus, Susan S Jick NLM Citation: Ayodele OA, Cabral HJ, McManus DD, Jick SS. Glucocorticoids and Risk of Venous Thromboembolism in…

A review of the evidence on the risk of congenital malformations and neurodevelopmental disorders in association with antiseizure medications during pregnancy

By BCDSP July 28, 2021Uncategorized

Journal: Expert Opinion on Drug Safety Authors: Carole A Marxer, Stephan Rüegg, Marlene S Rauch, Alice Panchaud, Christoph R Meier, Julia Spoendlin NLM Citation: Marxer CA, Rüegg S, Rauch MS, Panchaud A, Meier CR, Spoendlin…